Apotheek Sorgeloose SPRL
Apotheek Sorgeloose reported total assets of 5,649 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Apotheek Sorgeloose shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -96 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Sorgeloose's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 02 Oct 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Apotheek Sorgeloose's financial analysis
- Solvency-1378.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Sorgeloose
Apotheek Sorgeloose's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0885.537.447
- VAT number
- BE0885537447
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 05 Dec 2006
- Registered office
- 9041 Ghent
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Sorgeloose (SPRL) has been based in Ghent since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 3,388 € and equity of −77,864 €; its revenue is not published. Its solvency stands at -1378.4%, below the median of its sector (44.2%).
Companies similar to Apotheek Sorgeloose
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Apoteek't Groen Kruis Retail sale of pharmaceutical products Schoten · balance sheet 220,163 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
- Genaphar Retail sale of pharmaceutical products Brussels · balance sheet 147,330 €
- Pharma Danckaert Retail sale of pharmaceutical products Antwerp · balance sheet 132,287 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Cornut C Retail sale of pharmaceutical products Mons · balance sheet 43,250 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
Frequently asked questions about Apotheek Sorgeloose
What is the revenue of Apotheek Sorgeloose?
Apotheek Sorgeloose files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Sorgeloose?
In Belgium, the VAT number is the company number prefixed with BE: BE0885537447 for Apotheek Sorgeloose, if the company is VAT-registered. Its company number (CBE) is 0885.537.447.
Where is the registered office of Apotheek Sorgeloose?
According to the CBE register, the registered office of Apotheek Sorgeloose is in 9041 Ghent.
What is the equity of Apotheek Sorgeloose?
At the close of the 2025 financial year, the equity of Apotheek Sorgeloose amounts to -77,864 €, a solvency of -1378.4% of total assets.
Who manages Apotheek Sorgeloose?
The register lists 2 active mandates at Apotheek Sorgeloose. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Sorgeloose
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →